{"count":220363,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2066","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=2064","results":[{"created":"2019-12-06T18:53:39.147330+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.642","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ALDOA as ready","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:53:39.140262+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.642","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: aldoa has been classified as Amber List (Moderate Evidence).","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:53:32.937032+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.642","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ALDOA were changed from  to Glycogen storage disease XII, MIM#611881","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:53:20.453957+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.641","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ALDOA was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:53:05.812949+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.640","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ALDOA as Amber List (moderate evidence)","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:53:05.805634+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.640","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: aldoa has been classified as Amber List (Moderate Evidence).","entity_name":"ALDOA","entity_type":"gene"},{"created":"2019-12-06T18:52:10.138059+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.639","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AKR1C2 as ready","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:52:10.130745+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.639","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akr1c2 has been classified as Red List (Low Evidence).","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:52:03.847792+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.639","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AKR1C2 were changed from  to 46XY sex reversal 8, MIM#614279","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:51:48.666785+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.638","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AKR1C2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:51:32.436303+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.637","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AKR1C2 as Red List (low evidence)","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:51:32.428963+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.637","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akr1c2 has been classified as Red List (Low Evidence).","entity_name":"AKR1C2","entity_type":"gene"},{"created":"2019-12-06T18:50:03.876102+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.636","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AKAP6 as ready","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:50:03.868228+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.636","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akap6 has been classified as Amber List (Moderate Evidence).","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:48:26.826859+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.636","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AKAP6 were changed from  to Intellectual disability","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:48:02.524840+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.635","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: AKAP6 were set to ","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:47:49.120858+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.634","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AKAP6 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:47:41.933038+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.633","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AKAP6 as Amber List (moderate evidence)","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:47:41.923981+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.633","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: akap6 has been classified as Amber List (Moderate Evidence).","entity_name":"AKAP6","entity_type":"gene"},{"created":"2019-12-06T18:47:01.439075+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.632","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGTR2 as ready","entity_name":"AGTR2","entity_type":"gene"},{"created":"2019-12-06T18:47:01.431573+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.632","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agtr2 has been classified as Red List (Low Evidence).","entity_name":"AGTR2","entity_type":"gene"},{"created":"2019-12-06T18:46:54.737871+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.632","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGTR2 as Red List (low evidence)","entity_name":"AGTR2","entity_type":"gene"},{"created":"2019-12-06T18:46:54.731055+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.632","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agtr2 has been classified as Red List (Low Evidence).","entity_name":"AGTR2","entity_type":"gene"},{"created":"2019-12-06T18:46:07.990764+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.631","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGT as ready","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:46:07.983407+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.631","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agt has been classified as Red List (Low Evidence).","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:45:59.802553+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.631","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGT were changed from  to Renal tubular dysgenesis, MIM#267430","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:45:43.045272+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.630","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AGT was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:45:31.618531+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.629","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGT as Red List (low evidence)","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:45:31.611338+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.629","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agt has been classified as Red List (Low Evidence).","entity_name":"AGT","entity_type":"gene"},{"created":"2019-12-06T18:45:05.242408+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.628","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGPS as ready","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:45:05.234246+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.628","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agps has been classified as Red List (Low Evidence).","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:45:00.675438+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.628","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGPS were changed from  to Rhizomelic chondrodysplasia punctata, type 3, MIM#600121","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:44:45.980501+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.627","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AGPS was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:44:34.878097+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.626","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGPS as Red List (low evidence)","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:44:34.870861+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.626","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agps has been classified as Red List (Low Evidence).","entity_name":"AGPS","entity_type":"gene"},{"created":"2019-12-06T18:44:03.758382+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.625","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGK as ready","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:44:03.751283+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.625","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agk has been classified as Red List (Low Evidence).","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:43:59.401823+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.625","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AGK were changed from  to Sengers syndrome, MIM#212350","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:43:47.429986+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.624","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AGK was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:43:40.363692+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.623","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGK as Red List (low evidence)","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:43:40.356817+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.623","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: agk has been classified as Red List (Low Evidence).","entity_name":"AGK","entity_type":"gene"},{"created":"2019-12-06T18:43:12.296311+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.622","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AGGF1 as ready","entity_name":"AGGF1","entity_type":"gene"},{"created":"2019-12-06T18:43:12.289272+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.622","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: aggf1 has been classified as Red List (Low Evidence).","entity_name":"AGGF1","entity_type":"gene"},{"created":"2019-12-06T18:43:03.972678+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.622","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AGGF1 as Red List (low evidence)","entity_name":"AGGF1","entity_type":"gene"},{"created":"2019-12-06T18:43:03.965402+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.622","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: aggf1 has been classified as Red List (Low Evidence).","entity_name":"AGGF1","entity_type":"gene"},{"created":"2019-12-06T18:42:35.094888+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.621","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: AFG3L2 as ready","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:42:35.087671+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.621","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: afg3l2 has been classified as Red List (Low Evidence).","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:42:31.100369+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.621","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: AFG3L2 were changed from  to Spastic ataxia 5, autosomal recessive, MIM#614487","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:42:17.427955+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.620","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: AFG3L2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:42:05.334797+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.619","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: AFG3L2 as Red List (low evidence)","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:42:05.327235+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.619","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: afg3l2 has been classified as Red List (Low Evidence).","entity_name":"AFG3L2","entity_type":"gene"},{"created":"2019-12-06T18:41:19.576692+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: CHD1 as ready","entity_name":"CHD1","entity_type":"gene"},{"created":"2019-12-06T18:41:19.569743+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chd1 has been classified as Green List (High Evidence).","entity_name":"CHD1","entity_type":"gene"},{"created":"2019-12-06T18:41:13.545611+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: CHD1 as Green List (high evidence)","entity_name":"CHD1","entity_type":"gene"},{"created":"2019-12-06T18:41:13.536691+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.618","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: chd1 has been classified as Green List (High Evidence).","entity_name":"CHD1","entity_type":"gene"},{"created":"2019-12-06T18:39:45.277515+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.617","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADCY5 as ready","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:39:45.270486+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.617","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adcy5 has been classified as Red List (Low Evidence).","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:39:39.948620+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.617","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADCY5 were changed from  to Dyskinesia, familial, with facial myokymia, MIM#606703","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:39:24.787801+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.616","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ADCY5 was changed from Unknown to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:39:13.699720+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.615","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADCY5 as Red List (low evidence)","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:39:13.692777+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.615","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adcy5 has been classified as Red List (Low Evidence).","entity_name":"ADCY5","entity_type":"gene"},{"created":"2019-12-06T18:38:32.551975+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.614","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADAMTSL2 as ready","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:38:32.544560+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.614","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adamtsl2 has been classified as Red List (Low Evidence).","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:38:25.855831+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.614","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADAMTSL2 were changed from  to Geleophysic dysplasia 1, MIM#231050","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:38:09.440893+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.613","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ADAMTSL2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:37:58.632574+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.612","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADAMTSL2 as Red List (low evidence)","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:37:58.618142+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.612","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: adamtsl2 has been classified as Red List (Low Evidence).","entity_name":"ADAMTSL2","entity_type":"gene"},{"created":"2019-12-06T18:36:31.152080+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ADA2 as ready","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T18:36:31.144767+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ada2 has been classified as Red List (Low Evidence).","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T18:36:26.773232+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.611","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ADA2 were changed from  to Vasculitis, autoinflammation, immunodeficiency, and hematologic defects syndrome, MIM#615688","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T18:35:54.577984+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.610","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: ADA2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T18:35:43.628667+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ADA2 as Red List (low evidence)","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T18:35:43.621190+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.609","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: ada2 has been classified as Red List (Low Evidence).","entity_name":"ADA2","entity_type":"gene"},{"created":"2019-12-06T15:24:40.378973+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.168","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MIR17HG as ready","entity_name":"MIR17HG","entity_type":"gene"},{"created":"2019-12-06T15:24:40.370970+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.168","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mir17hg has been classified as Green List (High Evidence).","entity_name":"MIR17HG","entity_type":"gene"},{"created":"2019-12-06T15:24:31.337730+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.168","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: MIR17HG as Green List (high evidence)","entity_name":"MIR17HG","entity_type":"gene"},{"created":"2019-12-06T15:24:31.330200+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.168","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: mir17hg has been classified as Green List (High Evidence).","entity_name":"MIR17HG","entity_type":"gene"},{"created":"2019-12-06T15:24:11.020818+11:00","panel_name":"Mendeliome_VCGS","panel_id":137,"panel_version":"0.167","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MIR17HG was added\ngene: MIR17HG was added to Mendeliome_VCGS. Sources: Expert list\nMode of inheritance for gene: MIR17HG was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted\nPublications for gene: MIR17HG were set to 25391829; 21892160\nPhenotypes for gene: MIR17HG were set to Feingold syndrome 2; OMIM #614326\nReview for gene: MIR17HG was set to GREEN\nAdded comment: 4 unrelated cases reported - 3 with gene deletions, 1 with SNV \nSources: Expert list","entity_name":"MIR17HG","entity_type":"gene"},{"created":"2019-12-06T14:56:43.891512+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.608","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: MAP4K4 as ready","entity_name":"MAP4K4","entity_type":"gene"},{"created":"2019-12-06T14:56:43.884377+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.608","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: map4k4 has been classified as Red List (Low Evidence).","entity_name":"MAP4K4","entity_type":"gene"},{"created":"2019-12-06T14:56:31.558155+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.608","user_name":"Zornitza Stark","item_type":"entity","text":"gene: MAP4K4 was added\ngene: MAP4K4 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: MAP4K4 was set to Unknown\nReview for gene: MAP4K4 was set to RED\nAdded comment: Cannot find evidence for gene-disease association. \nSources: Expert list","entity_name":"MAP4K4","entity_type":"gene"},{"created":"2019-12-06T14:44:36.499037+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LZTR1 as ready","entity_name":"LZTR1","entity_type":"gene"},{"created":"2019-12-06T14:44:36.491830+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lztr1 has been classified as Green List (High Evidence).","entity_name":"LZTR1","entity_type":"gene"},{"created":"2019-12-06T14:44:30.929789+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: LZTR1 as Green List (high evidence)","entity_name":"LZTR1","entity_type":"gene"},{"created":"2019-12-06T14:44:30.922645+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.607","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lztr1 has been classified as Green List (High Evidence).","entity_name":"LZTR1","entity_type":"gene"},{"created":"2019-12-06T14:44:18.415894+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.606","user_name":"Zornitza Stark","item_type":"entity","text":"gene: LZTR1 was added\ngene: LZTR1 was added to Intellectual disability, syndromic and non-syndromic_GHQ. Sources: Expert list\nMode of inheritance for gene: LZTR1 was set to BOTH monoallelic and biallelic, autosomal or pseudoautosomal\nPhenotypes for gene: LZTR1 were set to Noonan syndrome 10, MIM#616564; Noonan syndrome 2, MIM#605275\nReview for gene: LZTR1 was set to GREEN\nAdded comment: Sources: Expert list","entity_name":"LZTR1","entity_type":"gene"},{"created":"2019-12-06T14:39:36.162509+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.605","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LAMB2 as ready","entity_name":"LAMB2","entity_type":"gene"},{"created":"2019-12-06T14:39:36.153997+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.605","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lamb2 has been classified as Green List (High Evidence).","entity_name":"LAMB2","entity_type":"gene"},{"created":"2019-12-06T14:39:30.924284+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.605","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LAMB2 were changed from  to Pierson syndrome, MIM#609049","entity_name":"LAMB2","entity_type":"gene"},{"created":"2019-12-06T14:38:56.138864+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.604","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LAMB2 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LAMB2","entity_type":"gene"},{"created":"2019-12-06T14:38:22.659774+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.603","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LAMB2: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Pierson syndrome, MIM#609049; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LAMB2","entity_type":"gene"},{"created":"2019-12-06T14:19:36.523195+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.603","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LZTFL1 as ready","entity_name":"LZTFL1","entity_type":"gene"},{"created":"2019-12-06T14:19:36.515817+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.603","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lztfl1 has been classified as Green List (High Evidence).","entity_name":"LZTFL1","entity_type":"gene"},{"created":"2019-12-06T14:19:32.879039+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.603","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LZTFL1 was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LZTFL1","entity_type":"gene"},{"created":"2019-12-06T14:19:19.850326+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.602","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LZTFL1: Rating: GREEN; Mode of pathogenicity: None; Publications: 22510444, 23692385, 27312011; Phenotypes: Bardet-Biedl syndrome 17, MIM#615994; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LZTFL1","entity_type":"gene"},{"created":"2019-12-06T14:13:46.721706+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.602","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: LYST as ready","entity_name":"LYST","entity_type":"gene"},{"created":"2019-12-06T14:13:46.714706+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.602","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: lyst has been classified as Green List (High Evidence).","entity_name":"LYST","entity_type":"gene"},{"created":"2019-12-06T14:13:42.594012+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.602","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: LYST were changed from  to Chediak-Higashi syndrome, MIM#214500","entity_name":"LYST","entity_type":"gene"},{"created":"2019-12-06T14:13:28.701415+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.601","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: LYST was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"LYST","entity_type":"gene"},{"created":"2019-12-06T14:13:14.846010+11:00","panel_name":"Intellectual disability, syndromic and non-syndromic_GHQ","panel_id":250,"panel_version":"0.600","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: LYST: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Chediak-Higashi syndrome, MIM#214500; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"LYST","entity_type":"gene"}]}